The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Single-Cell Genome Sequencing Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Single-Cell Genome Sequencing market size in 2022 is 2000.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 14.00% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Single-Cell Genome Sequencing market include Oxford Nanopore Technologies plc (U.K.), PacBio (U.S., Novogene Co, Ltd (China), Mission Bio (U.S)., and Fluxion Biosciences Inc (U.S.). The share of the top 3 players in the Single-Cell Genome Sequencing market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Single-Cell Genome Sequencing market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Single Cell Isolation accounted for XX% of Single-Cell Genome Sequencing market in 2022. Sample Preparation share of XX%.
Circulating Cells accounted for XX% of the Single-Cell Genome Sequencing market in 2022. Cell Differentiation accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Some prominent players in the market includes:
Oxford Nanopore Technologies plc (U.K.)
PacBio (U.S.
Novogene Co, Ltd (China)
Mission Bio (U.S).
Fluxion Biosciences Inc (U.S.)
Thermo Fisher Scientific (U.S.)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (U.S.)
McKesson Corporation (U.S)
Allscripts Healthcare, LLC, (U.S
Siemens, (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Bio-Rad Laboratories, Inc. (U.S.)
BGI (China)
B.D. (U.S.)
Danaher (U.S.)
Bruker (U.S.)
10x Genomics (U.S.)
Promega Corporation (U.S.)
Market Data Breakdown by Type
Single Cell Isolation
Sample Preparation
Genomic Analysis
Market Data Breakdown by Applications
Circulating Cells
Cell Differentiation
Genomic Variation
Subpopulation Characterization
Others
Table of Content
1 Study Coverage
1.1 Single-Cell Genome Sequencing Product Introduction
1.2 Global Single-Cell Genome Sequencing Outlook 2018 VS 2023 VS 2029
1.3 United States Single-Cell Genome Sequencing Outlook 2018 VS 2023 VS 2029
1.4 Single-Cell Genome Sequencing Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Single-Cell Genome Sequencing in Global, 2018-2029
1.4.2 The Growth Rate of Single-Cell Genome Sequencing Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Single-Cell Genome Sequencing Market Dynamics
1.5.1 Single-Cell Genome Sequencing Market Trends
1.5.2 Single-Cell Genome Sequencing Market Drivers
1.5.3 Single-Cell Genome Sequencing Market Challenges
1.5.4 Single-Cell Genome Sequencing Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Single-Cell Genome Sequencing Competitor Landscape by Company
2.1 Global Single-Cell Genome Sequencing Market Size by Company
2.1.1 Top Global Single-Cell Genome Sequencing Player Ranked by Revenue (2023)
2.1.2 Global Single-Cell Genome Sequencing Revenue by Player (2018-2023)
2.2 Global Single-Cell Genome Sequencing Concentration Ratio (CR)
2.2.1 Single-Cell Genome Sequencing Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Single-Cell Genome Sequencing in 2023
2.3 Global Single-Cell Genome Sequencing Business Distribution, Business Type
2.3.1 Global Single-Cell Genome Sequencing Players, Headquarters and Distribution
2.3.2 Players Single-Cell Genome Sequencing Business Type
2.3.3 Date of International Players Enter into Single-Cell Genome Sequencing Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Single-Cell Genome Sequencing Market Size by Company
2.5.1 Top United States Single-Cell Genome Sequencing Player s Ranked by Revenue (2023)
2.5.2 United States Single-Cell Genome Sequencing Revenue by Player (2018-2023)
3 Single-Cell Genome Sequencing Market Segment by Type
3.1 Single-Cell Genome Sequencing Market Segment by Type
3.2 Global Single-Cell Genome Sequencing Market Size by Type
3.3 United States Single-Cell Genome Sequencing Market Size by Type
4 Single-Cell Genome Sequencing by Market Segment Application
4.1 Single-Cell Genome Sequencing Market Segment by Application
4.2 Global Single-Cell Genome Sequencing Market Size by Application
4.3 United States Single-Cell Genome Sequencing Market Size by Application
5 Global Single-Cell Genome Sequencing Market Size by Region
5.1 Global Single-Cell Genome Sequencing Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Single-Cell Genome Sequencing Market Size in Value by Region (2018-2029)
5.2.1 Global Single-Cell Genome Sequencing Revenue by Region: 2018-2023
5.2.2 Global Single-Cell Genome Sequencing Revenue by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Single-Cell Genome Sequencing Market Size YoY Growth 2018-2029
6.1.2 North America Single-Cell Genome Sequencing Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Single-Cell Genome Sequencing Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Single-Cell Genome Sequencing Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Single-Cell Genome Sequencing Market Size YoY Growth 2018-2029
6.3.2 Europe Single-Cell Genome Sequencing Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Single-Cell Genome Sequencing Market Size YoY Growth 2018-2029
6.4.2 Latin America Single-Cell Genome Sequencing Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Single-Cell Genome Sequencing Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Single-Cell Genome Sequencing Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Oxford Nanopore Technologies plc (U.K.)
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Single-Cell Genome Sequencing Introduction
7.1.4 Oxford Nanopore Technologies plc (U.K.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.1.5 Oxford Nanopore Technologies plc (U.K.) Recent Development
7.2 PacBio (U.S.
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Single-Cell Genome Sequencing Introduction
7.2.4 PacBio (U.S. Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.2.5 PacBio (U.S. Recent Development
7.3 Novogene Co, Ltd (China)
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Single-Cell Genome Sequencing Introduction
7.3.4 Novogene Co, Ltd (China) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.3.5 Novogene Co, Ltd (China) Recent Development
7.4 Mission Bio (U.S).
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Single-Cell Genome Sequencing Introduction
7.4.4 Mission Bio (U.S). Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.4.5 Mission Bio (U.S). Recent Development
7.5 Fluxion Biosciences Inc (U.S.)
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Single-Cell Genome Sequencing Introduction
7.5.4 Fluxion Biosciences Inc (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.5.5 Fluxion Biosciences Inc (U.S.) Recent Development
7.6 Thermo Fisher Scientific (U.S.)
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Single-Cell Genome Sequencing Introduction
7.6.4 Thermo Fisher Scientific (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.6.5 Thermo Fisher Scientific (U.S.) Recent Development
7.7 QIAGEN (Netherlands)
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 Single-Cell Genome Sequencing Introduction
7.7.4 QIAGEN (Netherlands) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.7.5 QIAGEN (Netherlands) Recent Development
7.8 Agilent Technologies, Inc. (U.S.)
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 Single-Cell Genome Sequencing Introduction
7.8.4 Agilent Technologies, Inc. (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.8.5 Agilent Technologies, Inc. (U.S.) Recent Development
7.9 McKesson Corporation (U.S)
7.9.1 Company Details
7.9.2 Description and Business Overview
7.9.3 Single-Cell Genome Sequencing Introduction
7.9.4 McKesson Corporation (U.S) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.9.5 McKesson Corporation (U.S) Recent Development
7.10 Allscripts Healthcare, LLC, (U.S
7.10.1 Company Details
7.10.2 Description and Business Overview
7.10.3 Single-Cell Genome Sequencing Introduction
7.10.4 Allscripts Healthcare, LLC, (U.S Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.10.5 Allscripts Healthcare, LLC, (U.S Recent Development
7.11 Siemens, (Germany)
7.11.1 Company Details
7.11.2 Description and Business Overview
7.11.3 Single-Cell Genome Sequencing Introduction
7.11.4 Siemens, (Germany) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.11.5 Siemens, (Germany) Recent Development
7.12 F. Hoffmann-La Roche Ltd. (Switzerland)
7.12.1 Company Details
7.12.2 Description and Business Overview
7.12.3 Single-Cell Genome Sequencing Introduction
7.12.4 F. Hoffmann-La Roche Ltd. (Switzerland) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.12.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
7.13 Bio-Rad Laboratories, Inc. (U.S.)
7.13.1 Company Details
7.13.2 Description and Business Overview
7.13.3 Single-Cell Genome Sequencing Introduction
7.13.4 Bio-Rad Laboratories, Inc. (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.13.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Development
7.14 BGI (China)
7.14.1 Company Details
7.14.2 Description and Business Overview
7.14.3 Single-Cell Genome Sequencing Introduction
7.14.4 BGI (China) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.14.5 BGI (China) Recent Development
7.15 B.D. (U.S.)
7.15.1 Company Details
7.15.2 Description and Business Overview
7.15.3 Single-Cell Genome Sequencing Introduction
7.15.4 B.D. (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.15.5 B.D. (U.S.) Recent Development
7.16 Danaher (U.S.)
7.16.1 Company Details
7.16.2 Description and Business Overview
7.16.3 Single-Cell Genome Sequencing Introduction
7.16.4 Danaher (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.16.5 Danaher (U.S.) Recent Development
7.17 Bruker (U.S.)
7.17.1 Company Details
7.17.2 Description and Business Overview
7.17.3 Single-Cell Genome Sequencing Introduction
7.17.4 Bruker (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.17.5 Bruker (U.S.) Recent Development
7.18 10x Genomics (U.S.)
7.18.1 Company Details
7.18.2 Description and Business Overview
7.18.3 Single-Cell Genome Sequencing Introduction
7.18.4 10x Genomics (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.18.5 10x Genomics (U.S.) Recent Development
7.19 Promega Corporation (U.S.)
7.19.1 Company Details
7.19.2 Description and Business Overview
7.19.3 Single-Cell Genome Sequencing Introduction
7.19.4 Promega Corporation (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023)
7.19.5 Promega Corporation (U.S.) Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Single-Cell Genome Sequencing Value Chain Analysis
8.2 Single-Cell Genome Sequencing Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer
List of Tables and Figures
Figure Single-Cell Genome Sequencing Product Picture
Table Global Single-Cell Genome Sequencing Revenue, ($), 2018 VS 2023 VS 2029
Figure Global Single-Cell Genome Sequencing Market Size 2018-2029 ($)
Table United States Single-Cell Genome Sequencing Revenue, ($), 2018 VS 2023 VS 2029
Figure United States Single-Cell Genome Sequencing Market Size 2018-2029 ($)
Figure United States Single-Cell Genome Sequencing Market Share in Global, in Value 2018-2029
Table Single-Cell Genome Sequencing CAGR in Value, United States VS Global, 2018 VS 2023 VS 2029
Table Single-Cell Genome Sequencing Market Trends
Table Single-Cell Genome Sequencing Market Drivers
Table Single-Cell Genome Sequencing Market Challenges
Table Single-Cell Genome Sequencing Market Restraints
Figure Single-Cell Genome Sequencing Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Single-Cell Genome Sequencing Players in Global Market, Ranking by Revenue (2023)
Table Global Single-Cell Genome Sequencing Revenue by Player, ($), 2018-2023
Table Global Single-Cell Genome Sequencing Revenue Share by Player, 2018-2023
Table Global Single-Cell Genome Sequencing Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Single-Cell Genome Sequencing in the World: Market Share by Single-Cell Genome Sequencing Revenue in 2023
Table Top Players of Single-Cell Genome Sequencing in Global Market, Headquarters and Distribution
Table Players Single-Cell Genome Sequencing Business Type
Table Date of International Players Enter into Single-Cell Genome Sequencing Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Single-Cell Genome Sequencing Players in United States Market, Ranking by Revenue (2023)
Table United States Single-Cell Genome Sequencing Revenue by Player, ($), 2018-2023
Table United States Single-Cell Genome Sequencing Revenue Share by Player, 2018-2023
Table Global Single-Cell Genome Sequencing Revenue by Type: 2023 VS 2029 ($)
Figure Global Single-Cell Genome Sequencing Market Share by Type in 2023 & 2029
Figure Global Single-Cell Genome Sequencing Revenue by Type (2018-2029) & ($)
Figure Global Single-Cell Genome Sequencing Revenue Market Share in Value by Type (2018-2029)
Table United States Single-Cell Genome Sequencing Revenue by Type: 2023 VS 2029 ($)
Figure United States Single-Cell Genome Sequencing Market Share by Type in 2023 & 2029
Figure United States Single-Cell Genome Sequencing Revenue by Type (2018-2029) & ($)
Figure United States Single-Cell Genome Sequencing Revenue Market Share in Value by Type (2018-2029)
Table Global Single-Cell Genome Sequencing Revenue by Application: 2023 VS 2029 ($)
Figure Global Single-Cell Genome Sequencing Market Share by Application in 2023 & 2029
Figure Global Single-Cell Genome Sequencing Revenue by Application (2018-2029) & ($)
Figure Global Single-Cell Genome Sequencing Revenue Market Share in Value by Application (2018-2029)
Table United States Single-Cell Genome Sequencing Revenue by Application: 2023 VS 2029 ($)
Figure United States Single-Cell Genome Sequencing Market Share by Application in 2023 & 2029
Figure United States Single-Cell Genome Sequencing Revenue by Application (2018-2029) & ($)
Figure United States Single-Cell Genome Sequencing Revenue Market Share in Value by Application (2018-2029)
Table Global Single-Cell Genome Sequencing Market Size by Region ($): 2018 VS 2023 VS 2029
Figure Global Single-Cell Genome Sequencing Market Size Market Share by Region: 2018 VS 2023 VS 2029
Table Global Single-Cell Genome Sequencing Revenue by Region (2018-2023) & ($)
Table Global Single-Cell Genome Sequencing Revenue Forecast by Region (2023-2029) & ($)
Table Global Single-Cell Genome Sequencing Revenue Market Share by Region (2018-2029)
Figure North America Single-Cell Genome Sequencing Revenue Growth Rate 2018-2029
Table North America Single-Cell Genome Sequencing Revenue by Country (2018-2029) & ($)
Figure U.S. Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Canada Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Asia Pacific Single-Cell Genome Sequencing Revenue Growth Rate 2018-2029 ($)
Table Asia Pacific Single-Cell Genome Sequencing Revenue by Country (2018-2029) & ($)
Figure China Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Japan Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure South Korea Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure India Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Australia Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Southeast Asia Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Europe Single-Cell Genome Sequencing Revenue Growth Rate 2018-2029 ($)
Table Europe Single-Cell Genome Sequencing Revenue by Country (2018-2029) & ($)
Figure Germany Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure France Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure UK Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Italy Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Russia Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Latin America Single-Cell Genome Sequencing Revenue Growth Rate 2018-2029 ($)
Table Latin America Single-Cell Genome Sequencing Revenue by Country (2018-2029) & ($)
Figure Mexico Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Brazil Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Argentina Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Middle East and Africa Single-Cell Genome Sequencing Revenue Growth Rate 2018-2029 ($)
Table Middle East and Africa Single-Cell Genome Sequencing Revenue by Country (2018-2029) & ($)
Figure Turkey Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure Saudi Arabia Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Figure UAE Single-Cell Genome Sequencing Revenue Growth Rate (2018-2029) & ($)
Table Oxford Nanopore Technologies plc (U.K.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Oxford Nanopore Technologies plc (U.K.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Oxford Nanopore Technologies plc (U.K.) Recent Development
Table PacBio (U.S. Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table PacBio (U.S. Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table PacBio (U.S. Recent Development
Table Novogene Co, Ltd (China) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Novogene Co, Ltd (China) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Novogene Co, Ltd (China) Recent Development
Table Mission Bio (U.S). Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Mission Bio (U.S). Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Mission Bio (U.S). Recent Development
Table Fluxion Biosciences Inc (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Fluxion Biosciences Inc (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Fluxion Biosciences Inc (U.S.) Recent Development
Table Thermo Fisher Scientific (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Thermo Fisher Scientific (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Thermo Fisher Scientific (U.S.) Recent Development
Table QIAGEN (Netherlands) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table QIAGEN (Netherlands) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table QIAGEN (Netherlands) Recent Development
Table Agilent Technologies, Inc. (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Agilent Technologies, Inc. (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Agilent Technologies, Inc. (U.S.) Recent Development
Table McKesson Corporation (U.S) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table McKesson Corporation (U.S) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table McKesson Corporation (U.S) Recent Development
Table Allscripts Healthcare, LLC, (U.S Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Allscripts Healthcare, LLC, (U.S Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Allscripts Healthcare, LLC, (U.S Recent Development
Table Siemens, (Germany) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Siemens, (Germany) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Siemens, (Germany) Recent Development
Table F. Hoffmann-La Roche Ltd. (Switzerland) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table F. Hoffmann-La Roche Ltd. (Switzerland) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
Table Bio-Rad Laboratories, Inc. (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Bio-Rad Laboratories, Inc. (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Bio-Rad Laboratories, Inc. (U.S.) Recent Development
Table BGI (China) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table BGI (China) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table BGI (China) Recent Development
Table B.D. (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table B.D. (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table B.D. (U.S.) Recent Development
Table Danaher (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Danaher (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Danaher (U.S.) Recent Development
Table Bruker (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Bruker (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Bruker (U.S.) Recent Development
Table 10x Genomics (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table 10x Genomics (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table 10x Genomics (U.S.) Recent Development
Table Promega Corporation (U.S.) Company Details
Table Description and Business Overview
Table Single-Cell Genome Sequencing Introduction
Table Promega Corporation (U.S.) Single-Cell Genome Sequencing Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Promega Corporation (U.S.) Recent Development
Figure Single-Cell Genome Sequencing Value Chain
Table Major Customers of Single-Cell Genome Sequencing with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|